Diabetologia:强化血糖控制可降低糖尿病足溃疡风险

2014-05-12 佚名 丁香园

既往的研究结果提示,通过胰岛素强化治疗改善血糖控制,可降低1型糖尿病患者微血管和大血管并发症发生风险。然而,强化血糖控制对1型糖尿病患者皮肤微循环及缺血性足溃疡发生率的影响尚不清楚。 为此,来自瑞典卡罗琳斯卡医学院的Nyström教授及其团队进行了一项研究,探讨胰岛素强化治疗对1型糖尿病患者微循环的影响,以及其对1型糖尿病患者HbA1c和缺血性足溃疡发生率的影响。该研究结果在线发表在2014年0

既往的研究结果提示,通过胰岛素强化治疗改善血糖控制,可降低1型糖尿病患者微血管和大血管并发症发生风险。然而,强化血糖控制对1型糖尿病患者皮肤微循环及缺血性足溃疡发生率的影响尚不清楚。

为此,来自瑞典卡罗琳斯卡医学院的Nyström教授及其团队进行了一项研究,探讨胰岛素强化治疗对1型糖尿病患者微循环的影响,以及其对1型糖尿病患者HbA1c和缺血性足溃疡发生率的影响。该研究结果在线发表在2014年05月01日的Diabetologia杂志上。

斯德哥尔摩糖尿病干预研究中,1型糖尿病患者被随机分到胰岛素强化常规治疗(ICT)或标准治疗(ST),平均随访周期为7.5年。Nyström教授等对来自斯德哥尔摩糖尿病干预研究的72例1型糖尿病患者中,使用离子电渗透法将以下血管活性刺激物导入局部皮肤:乙酰胆碱(ACh)、硝普钠(SNP)和辣椒素,重新确定72例患者(ICT组35例;ST组37例)的皮肤微循环。前瞻性的收集这72例患者1990年至1995年期间HbA1c水平,并检测其与皮肤微循环的关系。对这些患者进行随访,直到患者首次因缺血性足溃疡住院治疗,或者直到2011年。的后继研究。

该研究发现,平均28年随访期间,ICT组有2例患者发生缺血性足溃疡,而ST组患者有10例发生缺血性足溃疡。在进行离子电渗透治疗时,ICT组患者的平均HbA1c水平低于ST组,分别为57mmol/l和68mmol/l。ICT组经ACh、SNP和辣椒素刺激后,血流灌注量显著增加,且高于ST组,分别为8.1PU vs 5.3PU、8.1PU vs 5.6PU和5.0PU vs 3.4PU。HbA1c水平与ACh和辣椒素诱导的血管舒张功能独立相关。

该研究提示,改善1型糖尿病患者的血糖控制,可使患者皮肤微循环得到改善,并可降低缺血性足溃疡发生率和截肢风.

原始出处

Rathsman B1, Jensen-Urstad K, Nyström T.Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study.Diabetologia. 2014 May 7.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1648541, encodeId=59e01648541de, content=<a href='/topic/show?id=531793000f9' target=_blank style='color:#2F92EE;'>#足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93000, encryptionId=531793000f9, topicName=足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=943123606403, createdName=meichuangyi, createdTime=Thu Jun 26 04:13:00 CST 2014, time=2014-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636861, encodeId=cd8d1636861bd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 10 04:13:00 CST 2014, time=2014-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759442, encodeId=fad81e59442bb, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 13 11:13:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041971, encodeId=451920419e11b, content=<a href='/topic/show?id=85055014226' target=_blank style='color:#2F92EE;'>#强化血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50142, encryptionId=85055014226, topicName=强化血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 31 04:13:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272905, encodeId=055d12e290534, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512532, encodeId=4d0c151253253, content=<a href='/topic/show?id=881ce679132' target=_blank style='color:#2F92EE;'>#糖尿病足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76791, encryptionId=881ce679132, topicName=糖尿病足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50210475224, createdName=ms3875500703114551, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1648541, encodeId=59e01648541de, content=<a href='/topic/show?id=531793000f9' target=_blank style='color:#2F92EE;'>#足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93000, encryptionId=531793000f9, topicName=足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=943123606403, createdName=meichuangyi, createdTime=Thu Jun 26 04:13:00 CST 2014, time=2014-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636861, encodeId=cd8d1636861bd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 10 04:13:00 CST 2014, time=2014-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759442, encodeId=fad81e59442bb, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 13 11:13:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041971, encodeId=451920419e11b, content=<a href='/topic/show?id=85055014226' target=_blank style='color:#2F92EE;'>#强化血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50142, encryptionId=85055014226, topicName=强化血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 31 04:13:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272905, encodeId=055d12e290534, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512532, encodeId=4d0c151253253, content=<a href='/topic/show?id=881ce679132' target=_blank style='color:#2F92EE;'>#糖尿病足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76791, encryptionId=881ce679132, topicName=糖尿病足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50210475224, createdName=ms3875500703114551, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1648541, encodeId=59e01648541de, content=<a href='/topic/show?id=531793000f9' target=_blank style='color:#2F92EE;'>#足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93000, encryptionId=531793000f9, topicName=足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=943123606403, createdName=meichuangyi, createdTime=Thu Jun 26 04:13:00 CST 2014, time=2014-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636861, encodeId=cd8d1636861bd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 10 04:13:00 CST 2014, time=2014-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759442, encodeId=fad81e59442bb, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 13 11:13:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041971, encodeId=451920419e11b, content=<a href='/topic/show?id=85055014226' target=_blank style='color:#2F92EE;'>#强化血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50142, encryptionId=85055014226, topicName=强化血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 31 04:13:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272905, encodeId=055d12e290534, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512532, encodeId=4d0c151253253, content=<a href='/topic/show?id=881ce679132' target=_blank style='color:#2F92EE;'>#糖尿病足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76791, encryptionId=881ce679132, topicName=糖尿病足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50210475224, createdName=ms3875500703114551, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]
    2014-06-13 智智灵药
  4. [GetPortalCommentsPageByObjectIdResponse(id=1648541, encodeId=59e01648541de, content=<a href='/topic/show?id=531793000f9' target=_blank style='color:#2F92EE;'>#足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93000, encryptionId=531793000f9, topicName=足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=943123606403, createdName=meichuangyi, createdTime=Thu Jun 26 04:13:00 CST 2014, time=2014-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636861, encodeId=cd8d1636861bd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 10 04:13:00 CST 2014, time=2014-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759442, encodeId=fad81e59442bb, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 13 11:13:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041971, encodeId=451920419e11b, content=<a href='/topic/show?id=85055014226' target=_blank style='color:#2F92EE;'>#强化血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50142, encryptionId=85055014226, topicName=强化血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 31 04:13:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272905, encodeId=055d12e290534, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512532, encodeId=4d0c151253253, content=<a href='/topic/show?id=881ce679132' target=_blank style='color:#2F92EE;'>#糖尿病足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76791, encryptionId=881ce679132, topicName=糖尿病足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50210475224, createdName=ms3875500703114551, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1648541, encodeId=59e01648541de, content=<a href='/topic/show?id=531793000f9' target=_blank style='color:#2F92EE;'>#足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93000, encryptionId=531793000f9, topicName=足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=943123606403, createdName=meichuangyi, createdTime=Thu Jun 26 04:13:00 CST 2014, time=2014-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636861, encodeId=cd8d1636861bd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 10 04:13:00 CST 2014, time=2014-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759442, encodeId=fad81e59442bb, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 13 11:13:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041971, encodeId=451920419e11b, content=<a href='/topic/show?id=85055014226' target=_blank style='color:#2F92EE;'>#强化血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50142, encryptionId=85055014226, topicName=强化血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 31 04:13:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272905, encodeId=055d12e290534, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512532, encodeId=4d0c151253253, content=<a href='/topic/show?id=881ce679132' target=_blank style='color:#2F92EE;'>#糖尿病足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76791, encryptionId=881ce679132, topicName=糖尿病足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50210475224, createdName=ms3875500703114551, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1648541, encodeId=59e01648541de, content=<a href='/topic/show?id=531793000f9' target=_blank style='color:#2F92EE;'>#足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93000, encryptionId=531793000f9, topicName=足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=943123606403, createdName=meichuangyi, createdTime=Thu Jun 26 04:13:00 CST 2014, time=2014-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636861, encodeId=cd8d1636861bd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jun 10 04:13:00 CST 2014, time=2014-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759442, encodeId=fad81e59442bb, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 13 11:13:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041971, encodeId=451920419e11b, content=<a href='/topic/show?id=85055014226' target=_blank style='color:#2F92EE;'>#强化血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50142, encryptionId=85055014226, topicName=强化血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Mar 31 04:13:00 CST 2015, time=2015-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272905, encodeId=055d12e290534, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512532, encodeId=4d0c151253253, content=<a href='/topic/show?id=881ce679132' target=_blank style='color:#2F92EE;'>#糖尿病足溃疡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76791, encryptionId=881ce679132, topicName=糖尿病足溃疡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a50210475224, createdName=ms3875500703114551, createdTime=Wed May 14 00:13:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]

相关资讯

JACC:“代谢健康肥胖”再遭质疑

既往有专家认为,不伴代谢异常的肥胖是“代谢健康肥胖”。近年来,陆续有研究质疑这一观点。近日,一项韩国研究再次提出质疑,该研究显示,与体重正常者相比,无心血管病的成年肥胖患者冠脉钙化风险明显升高。 该研究入选14 828例无心血管病的“代谢健康”(不存在代谢综合征及其组成成分且稳态模型胰岛素抵抗指数<2.5)成年受试者,平均体质指数23 kg/m2。研究者发现,代谢健康肥胖受试者中冠脉钙

Diabetes care:减压鞋可减少糖尿病足底溃疡复发

足底溃疡复发是糖尿病一个常见而重要的问题,但其机制尚不清楚。有研究表明,足部生物力学和患者行为可能在足底溃疡复发中发挥重要作用。为了明确糖尿病患者足部溃疡复发的危险因素,并确定足部溃疡预防的靶向目标,来自荷兰阿姆斯特丹大学学术医疗中心的Sicco Bus教授及其团队进行了一项研究。该研究结果在线发表在2014年04月17日的Diabetes care杂志上。【原文下载】该研究对171例近期神经性足

JAMA:美国青少年糖尿病患病率概况

虽然人们关注糖尿病的流行,但是,美国不同种族1型糖尿病和2型糖尿病流行趋势方面的数据有限。为此,来自美国科罗拉多大学公共卫生学院的Dabelea教授及其团队进行了一项研究,评估2001年至2009年期间,不同性别、不同年龄和不同种族的美国青少年中1型糖尿病和2型糖尿病患病率变化。该研究结果发表在2014年05月07日的the Journal of the American Medical Asso

环境or基因:为什么中国人爱得糖尿病?

自然环境变化的太快,人体基因进化太慢富足的生活来得太匆匆,而饥馑的记忆还留在身体里。一种慢性疾病的蔓延,是生活方式与遗传素质交互作用的结果,也是几十年社会生活的巨大变迁,给我们的身体留下的印痕。1992年,,美国加州大学洛杉矶分校医学院教授贾雷德?戴蒙德在《自然》杂志上撰文说,“中国人的生活方式正在改变,糖尿病将引发严重的公共健康问题”。戴蒙德的这个预言并没有引起太多的注意——他最令人瞩目的成

Diabetes Obes Metab:依帕列净多重功效获新证据

近期发表的一项囊括10项随机对照研究的Meta分析表明,对于2型糖尿病患者,与安慰剂相比,钠葡萄糖共同转运蛋白2(SGLT-2)抑制剂依帕列净(empagliflozin)除了能有效降低血糖外,还有助于减轻体重和降低血压。(Diabetes Obes Metab. 2014年4月26日在线版)在该分析中,依帕列净以10 mg或25 mg应用对HbA1c水平的降低效果均显著优于安慰剂,其中25 mg

糖尿病及糖尿病肾病合并急性肾损伤的诊断和治疗

糖尿病是一组代谢性疾病,其特点是慢性的高血糖伴有糖、脂肪和蛋白质的代谢紊乱,最终造成各种器官的功能障碍和衰竭。 糖尿病肾病是糖尿病最常见的微血管并发症,也是临床常见病、多发病,随着糖尿病和糖尿病肾病发病率的增加,合并急性肾损伤(acute kidney injury, AKI)的患者也有所增加,尤其是老年患者更易发生。 如诊断和治疗不及时,短时期内可出现肾功能恶化,甚至死亡。本文就糖尿病和